<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00750438</url>
  </required_header>
  <id_info>
    <org_study_id>08/H0707/99</org_study_id>
    <nct_id>NCT00750438</nct_id>
  </id_info>
  <brief_title>Effect of Fibre Products on Appetite and Weight</brief_title>
  <official_title>Increased Short Chain Fatty Acids in the Colon Are Associated With Improved Energy Homeostasis and Insulin Sensitivity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study explores the nutritional effects of fibre. Short chain fatty acid(SCFA), such as
      propionate, are produced through the fermentation of fibre in the bowel. SCFA are thought to
      have direct beneficial effects on the gut, appetite, weight and fat distribution. This study
      will look into these effects by conducting a dose finding study and then a randomised
      controlled study using healthy human volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a dose finding study in healthy overweight to obese human volunteers (BMI 25- 35) to
      find the level of oral supplementation with propionate that increases plasma propionate
      levels to 10x the current normal plasma level and use this dose of propionate in a
      randomised, placebo controlled double bind study. This study will compare propionate with
      fermentable and non fermentable carbohydrate. The outcome measures for this study will
      include assessments of appetite with feeding studies, measurement of insulin sensitivity
      using hyperinsulinaemic euglycaemic clamps and assessment of adipose tissue distribution
      using MRI scans and adipose tissue biopsy to determine changes in proliferation and
      differentiation of adipocytes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Appetite,</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Body weight</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adipose tissue distribution,</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Propionate ester</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fermentable control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Non fermentable control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Propionate ester</intervention_name>
    <description>The subject will take propionate ester at the dose specified by the dose finding study, three times a day for 24 weeks</description>
    <arm_group_label>Propionate ester</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Inulin</intervention_name>
    <description>The subjects in this group will take inulin at a comparable dose, three times a day for 24 weeks</description>
    <arm_group_label>Fermentable control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cellulose</intervention_name>
    <description>The subjects in this group will take the non fermentable carbohydrate, cellulose, at a comparable dose for 24 weeks.</description>
    <arm_group_label>Non fermentable control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male and female volunteers aged between 21 and 65 years

        Exclusion Criteria:

          -  Weight change of more than 3kg in the preceding 2 months

          -  Current smokers

          -  Substance abuse

          -  Excess alcohol intake

          -  Pregnancy

          -  Diabetes

          -  Cardiovascular disease

          -  Cancer

          -  Gastrointestinal disease e.g. inflammatory bowel disease or irritable bowel syndrome

          -  Kidney disease

          -  Liver disease

          -  Pancreatitis

          -  Use of medications including: anti inflammatory drugs or steroids, cholesterol
             lowering medication, androgens, phenytoin, erythromycin or thyroid hormones.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary Frost, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <state>UK</state>
        <zip>W12 0NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2008</study_first_submitted>
  <study_first_submitted_qc>September 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2008</study_first_posted>
  <last_update_submitted>November 18, 2016</last_update_submitted>
  <last_update_submitted_qc>November 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Short chain fatty acids</keyword>
  <keyword>Appetite</keyword>
  <keyword>Body weight</keyword>
  <keyword>Insulin sensitivity</keyword>
  <keyword>Propionate</keyword>
  <keyword>Propionate ester</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

